Light-Triggered Structural Changes in Biologics
Available from Pharma SOP:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Stability data, especially from accelerated studies, often contains subtle trends that require statistical evaluation to detect, understand, and predict degradation behavior. Statistical modeling ensures consistency, supports shelf life claims, and enables extrapolation — particularly when real-time data is incomplete.
Click to read the full article.
New impurities are degradation products that appear over time during real-time storage but were not previously identified during forced degradation or accelerated studies.
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Stability studies evaluate how the quality of a pharmaceutical product varies with time under the influence of environmental factors such as temperature, humidity, and light. These evaluations rely on the accuracy and sensitivity of the analytical methods used to detect changes — especially degradation.
Click to read the full article.
Stability chambers simulate real-time and accelerated environmental conditions required under ICH Q1A(R2). If the chamber fails to maintain temperature or relative humidity within specified ranges, the data generated may be invalid, leading to regulatory non-compliance, product recall, or data rejection during submission.
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Risk-based stability study design focuses on identifying and mitigating potential risks that could affect product quality, shelf life, and regulatory compliance. Rather than testing every variable exhaustively, resources are directed where the risk is highest.
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
